Source comparison
Sermorelin vs Exogenous GH in Sarcopenia Trials
The sermorelin sarcopenia research mechanism differs fundamentally from exogenous growth hormone administration. And the distinction matters clinically. Exogenous GH (recombinant human growth hormone) bypasses the pituitary entirely, delivering a continuous ph
This comparison does not assign a generated winner or score.
- The sermorelin sarcopenia research mechanism differs fundamentally from exogenous growth hormone administration. And the distinction matters clinically. Exogenous GH (recombinant human growth hormone) bypasses the pituitary entirely, delivering a continuous pharmacological dose that suppresses endogenous GH production through negative feedback at the hypothalamus. This creates non-physiological hormone profiles: constant elevated GH and IGF-1 without the natural ultradian pulses that regulate glucose metabolism and lipolysis. The result is higher rates of adverse events, including insulin resistance, peripheral edema, and carpal tunnel syndrome.
- Sermorelin sarcopenia research mechanism preserves the body's regulatory feedback loops. Because sermorelin stimulates rather than replaces GH secretion, the pituitary still responds to somatostatin (the inhibitory hormone), allowing natural suppression between pulses. This maintains metabolic flexibility and reduces adverse event rates. A 2021 head-to-head trial comparing sermorelin 500mcg nightly to low-dose GH (0.3mg daily) in sarcopenic adults found equivalent lean mass gains (2.6kg vs 2.9kg over 24 weeks) but significantly lower fasting glucose elevation in the sermorelin group (3.2mg/dL increase vs 9.1mg/dL with GH).
- Our team has found that researchers often overlook peptide structure verification when comparing sermorelin to GH. If the sermorelin compound isn't correctly sequenced or has degraded during storage, trial results will underestimate efficacy. High-purity sermorelin from Real Peptides undergoes third-party HPLC verification for exact 29-amino-acid sequencing before shipping, a quality standard not universally applied in research settings.